arrow
H

Hongcheng Zhu

north china university of science & technology
H指数:30
被引数:2,802

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trials

食管鳞状细胞癌的术后化放疗:来自ESO-Shanghai 17和联合分析的II期临床试验结果

2025-11-210
OAAI
Corrigendum to “Lung cancer survival in China and world-wide: results from CONCORD-3” [The Lancet Regional Health–Western Pacific, Volume 55, Supplement 1, February 2025, 101371]

勘误:“中国与世界范围的肺癌生存率:CONCORD-3研究的结果” [《柳叶刀·区域健康—西太平洋》第55卷,第1期增刊,2025年2月,101371]

2025-10-170
OAAI
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCC

ESO-上海20:局部干预联合抗PD-1疗法治疗寡转移性ESCC的III期临床试验

2025-07-300
OA
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study

全球放射治疗需求和相应的放射治疗专业劳动力需求2022年和预测2050年: 一项基于人群的研究

2024-12-010
PRE
Young oncologists' perspective on the role and future of the clinician-scientist in oncology
2023-10-013
OAAI